Bradley Stockard, PharmD, PhD
Assistant Professor
Locations
- MCW Pharmacy School
HRC H2714
Contact Information
Education
PharmD, University of Missouri – Kansas City
PhD, Pharmaceutical Sciences, University of Florida
Fellowship, Clinical Pharmacology, Children’s Mercy Hospital, Kansas City
Certifications
BLS Provider
Techniques in Modeling Human Cancer in Mice, Jackson Laboratory
Bloodborne Pathogen Training
Hazardous Waste Management
Biography
Bradley Stockard, PharmD, PhD joined the MCW School of Pharmacy on August 15, 2022. He received his PharmD from the University of Missouri – Kansas City School of Pharmacy and PhD in Pharmaceutical Sciences from the University of Florida. He is a graduate of the Clinical Pharmacology T32 Fellowship program which he completed at Children’s Mercy Hospital in Kansas City, MO. He served as Chief Fellow from 2021-2022. During his fellowship, he completed a research rotation with the Center for Drug Evaluation and Research department at the FDA. His research interests are in multi-omics association studies on variations in treatment outcomes for pediatric leukemias and neonatology. He has presented his research at American Society of Hematology and American Society of Clinical Pharmacology and Therapeutic Annual Conferences.
Research Interests
Clinical Implementation of Pharmacogenomics
- Pharmacogenomics of Variable Response to Chemotherapy
- Cancer Metabolism and Metabolomics
- Multi-omics of Variable Drug Response in Neonatology
Publications
-
(Krzyzanski W, Stockard B, Gaedigk A, Scott A, Nolte W, Gibson K, Leeder JS, Lewis T.) CPT Pharmacometrics Syst Pharmacol. 2023 Jan;12(1):110-121 PMID: 36309972 PMCID: PMC9835126 SCOPUS ID: 2-s2.0-85143330863 10/31/2022
-
(Stockard B, Gauldin C, Truog W, Lewis T.) Front Pediatr. 2022;10:898806 PMID: 35757122 PMCID: PMC9226475 06/28/2022
-
Cellular Metabolomics Profiles Associated With Drug Chemosensitivity in AML.
(Stockard B, Bhise N, Shin M, Guingab-Cagmat J, Garrett TJ, Pounds S, Lamba JK.) Front Oncol. 2021;11:678008 PMID: 34178663 PMCID: PMC8222790 06/29/2021
-
(Stockard B, Garrett T, Guingab-Cagmat J, Meshinchi S, Lamba J.) Sci Rep. 2018 Apr 03;8(1):5534 PMID: 29615816 PMCID: PMC5882915 SCOPUS ID: 2-s2.0-85044960799 04/05/2018
-
(Singh S, McDonough CW, Gong Y, Alghamdi WA, Arwood MJ, Bargal SA, Dumeny L, Li WY, Mehanna M, Stockard B, Yang G, de Oliveira FA, Fredette NC, Shahin MH, Bailey KR, Beitelshees AL, Boerwinkle E, Chapman AB, Gums JG, Turner ST, Cooper-DeHoff RM, Johnson JA.) J Am Heart Assoc. 2018 Mar 09;7(6) PMID: 29523524 PMCID: PMC5907544 SCOPUS ID: 2-s2.0-85043690282 03/11/2018
I believe that teachers should expect to engage students and motivate them to learn with enthusiasm. My hope is that students leave my class not just with knowledge but also with an understanding of why it is important for patient care. It is increasingly important to treat patients as individuals as they respond to pharmacotherapy. My goal is to communicate that importance to students so that they can recognize these differences and adjust treatments proactively.
Bradley Stockard, PharmD, PhD